The European Academies’ Science Advisory Council (EASAC) statement ‘Homeopathic products and practices’
ECCH represents 26 associations of homeopaths across Europe, ensuring patients have access to high quality homeopathic treatment. This statement clarifies some points in relation to the recent statement by EASAC on homeopathy. (1)
- EASAC is independent of the European Union and was not commissioned to write this report by the European Parliament or DGSante, the European Health Commission.
- Citizens have the right to access the healthcare of their choice. The rights of European citizens to access complementary and alternative medicine, including homeopathy, was agreed by the European Parliament in February 2017. (2)
- There is evidence that demonstrates homeopathy’s mechanism of action which has been ignored or unfairly dismissed by EASAC (3)(4)
- Homeopathic medicines are already well regulated in the EU. (5)
- Homeopathy is safe; few adverse effects have been reported. (6)
Patients are not well served by this biased report. ECCH looks forward to collaboration with other organizations throughout Europe to seek positive dialogue with EASAC at EU and national level to discuss a more realistic approach to evaluating homeopathy research.
- European Academies’ Science Advisory Council. Homeopathic products and practices: assessing the evidence and ensuring consistency in regulating medical claims in the EU. http://www.easac.eu/home/reports-and-statements/detail-view/article/homeopathic.html
- Ed Chaplin C. Special issue: The Memory of Water. Homeopathy (2007):96;141-230
- Mathie RT. Controlled clinical studies of homeopathy. Homeopathy 2015;104:328-332